Preliminary findings reveal that both enantiomers of closantel show antimicrobial activity in Gram-positive bacteria, suggesting potential usage.
These preliminary findings suggest that both enantiomers are effective as monotherapy and contribute to the promising antimicrobial activity of CLO against GPB.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: